 |
|
Prevalence and risk factors of the metabolic syndrome in young adults with childhood-onset hypopituitary growth hormone deficiency
Han Hyuk Lim (Lim HH), Min Jae Kang (Kang MJ), In Suk Yun (Yun IS), Young Ah Lee (Lee YA), Choong Ho Shin (Shin CH), Sei Won Yang (Yang SW)
Clin Exp Pediatr. 2010;53(10):892-897. Published online 2010 Oct 31 DOI: https://doi.org/10.3345/kjp.2010.53.10.892
|
|
Citations to this article as recorded by
 Dyslipidaemia and growth hormone deficiency – A comprehensive review
Matthias Hepprich, Fahim Ebrahimi, Emanuel Christ
Best Practice & Research Clinical Endocrinology & .2023; 37(6): 101821. CrossRef Metabolic Impacts of Discontinuation and Resumption of Recombinant Human Growth Hormone Treatment during the Transition Period in Patients with Childhood-Onset Growth Hormone Deficiency
Yun Jeong Lee, Yunha Choi, Han-Wook Yoo, Young Ah Lee, Choong Ho Shin, Han Saem Choi, Ho-Seong Kim, Jae Hyun Kim, Jung Eun Moon, Cheol Woo Ko, Moon Bae Ahn, Byung-Kyu Suh, Jin-Ho Choi
Endocrinology and Metabolism.2022; 37(2): 359. CrossRef Safety of current recombinant human growth hormone treatments for adults with growth hormone deficiency and unmet needs
Charlotte Höybye, Paolo Beck-Peccoz, Suat Simsek, Markus Zabransky, Hichem Zouater, Günter Stalla, Robert D Murray
Expert Opinion on Drug Safety.2020; 19(12): 1539. CrossRef Metabolic syndrome induced by anticancer treatment in childhood cancer survivors
Hee Won Chueh, Jae Ho Yoo
Annals of Pediatric Endocrinology & Metabolism.2017; 22(2): 82. CrossRef
|